← AbbVie
Episodes featuring AbbVie
12 episodes, newest first.
- Oct 6, 2026
Genmab trial lifts shares as BPCE expands into SabadellStock MoversOct 6, 2026 - Sep 23, 2026
A filmmaker turns nursing-home neglect into a reform movementTony Mantor: Why Not Me ?Sep 23, 2026 - Sep 14, 2026
AI safety fight collides with markets and midterm politicsWSJ What’s NewsSep 14, 2026 - Aug 17, 2026
Alec Litowitz argues adaptability beats certainty in investingHow I Invest with David WeisburdAug 17, 2026 - Aug 11, 2026
How algorithms turn health anxiety into a marketThis Podcast Will Kill YouAug 11, 2026 - Jul 16, 2026
Netflix slips on weak guidance while Abbott and Eli Lilly surgeStock MoversJul 16, 2026 - Jul 16, 2026
Mixed earnings forecasts trigger sharp stock swings for major market playersStock MoversJul 16, 2026 - Jun 30, 2026
AI fears sink Concentrix while lawmakers target Merck and AbbVie trialsStock MoversJun 30, 2026 - Jun 30, 2026
European stocks surge as AI demand and biotech breakthroughs shift capitalStock MoversJun 30, 2026 - Jun 30, 2026
European stocks surge as Abivax and Maersk upgrade market outlooksStock MoversJun 30, 2026 - Jun 22, 2026
AbbVie targets Apogee in eleven billion dollar deal as Regenxbio advancesStock MoversJun 22, 2026 - Jun 22, 2026
Acquisition rumors and major AI alliances spark pre-market stock surgesStock MoversJun 22, 2026